Edgewise Therapeutics Inc. – Filings and Transcripts

NASDAQ: EWTX
Share price (7/8/26): $46.30
Market cap (7/8/26): $4.982 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Ownership Filter

News Filter

Shareholder Vote Results

Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications

Reports Fourth Quarter and Full Year 2025 Financial Results With Strong Progress Across Muscular Dystrophy and Cardiovascular Programs

Appoints Commercial Biotech Executive Christopher Martin to Its Board of Directors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC